Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-25 @ 4:12 PM
Study NCT ID:
NCT01891357
Status:
TERMINATED
Last Update Posted:
2019-09-17
First Post:
2013-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Sponsor:
West German Study Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-14
First Submit QC Date:
None
Study First Post Date:
2013-07-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-12
Results First Submit QC Date:
None
Results First Post Date:
2019-09-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-16
Last Update Post Date:
2019-09-17
Last Update Post Date Type:
ACTUAL